Interpublic Group Of Cos., Inc (NYSE: IPG): Hunting Genuine Value In Market Debris

Currently, there are 372.40M common shares owned by the public and among those 371.25M shares have been available to trade.

Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.

The company’s stock has a 5-day price change of -3.85% and -12.37% over the past three months. IPG shares are trading -4.68% year to date (YTD), with the 12-month market performance down to -14.94% lower. It has a 12-month low price of $26.30 and touched a high of $35.17 over the same period. IPG has an average intraday trading volume of 6.12 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -2.42%, -4.18%, and -10.34% respectively.

Institutional ownership of Interpublic Group Of Cos., Inc (NYSE: IPG) shares accounts for 100.93% of the company’s 372.40M shares outstanding.

It has a market capitalization of $9.95B and a beta (3y monthly) value of 1.03. The stock’s trailing 12-month PE ratio is 14.62, while the earnings-per-share (ttm) stands at $1.83. The company has a PEG of 4.47 and a Quick Ratio of 1.09 with the debt-to-equity ratio at 1.12. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.55% over the week and 2.43% over the month.

Earnings per share for the fiscal year are expected to decrease by -4.32%, and 7.75% over the next financial year. EPS should grow at an annualized rate of 3.27% over the next five years, compared to 1.71% over the past 5-year period.

JP Morgan was of a view on January 27, 2025 that the stock is Overweight, while Barclays gave the stock Overweight rating on January 24, 2025, issuing a price target of $32- $36. Exane BNP Paribas on their part issued Outperform rating on January 10, 2025.

Most Popular

Related Posts